Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Roche Diagnostics and Exiqon have entered into a license agreement for use of SYBR Green reagent in the polymerase chain reaction. Financial terms of the agreement were not disclosed.
Subscribe to our email newsletter
Under the terms of the agreement, Exiqon obtains from Roche a non-exclusive license to use SYBR Green I in real time polymerase chain reaction (PCR).
SYBR Green provides the simplest and most economical format for detecting and quantitating PCR products in real-time PCR reactions, said Roche Diagnostics.
Roche and Exiqon have recently signed an amendment to their 2005 license and distribution agreement for Exiqon’s Universal ProbeLibrary.
Manfred Baier, head of Roche Applied Science, a business area of Roche Diagnostics, said: “From our view, the licensing of the use of SYBR Green reagent in real time PCR reaction is an important contribution to further developing the PCR technology in the life science field.”